If you've been in a radiology department recently, you might have noticed something unusual — patients are no longer getting lead aprons for routine X-rays. After more than 70 years as standard practice, patient shielding is being phased out across North America.
This shift has left many technologists, patients, and even instructors asking: Is shielding really obsolete? What happened to ALARA? Did they just throw out radiation safety?
Let's clear up the confusion.
Yes, routine patient shielding (lead aprons, gonad shields) is considered obsolete for diagnostic X-ray imaging. The American Association of Physicists in Medicine (AAPM) issued Position Statement PS 8-A in 2019 recommending its discontinuation, and virtually every major radiology organization has endorsed it since.
No, ALARA is NOT gone. The As Low As Reasonably Achievable principle remains the foundation of radiation safety. It has simply evolved to reflect better science and modern technology.
Patient shielding dates back to the 1950s, when concerns about radiation-induced genetic effects led to routine gonadal shielding. At the time, X-ray equipment delivered much higher doses, and the understanding of radiation risk was far less refined.
Lead aprons and gonad shields became a visible symbol of radiation safety — so ingrained that both patients and staff expected them. But as imaging technology advanced and radiation science matured, the evidence supporting routine shielding began to unravel.
The AAPM's position (endorsed by ACR, RSNA, Image Gently, HPS, and their Canadian counterparts) is based on three key findings:
Diagnostic X-ray doses are far below the threshold for measurable harm to the gonads or fetus. According to the ICRP (2007), no human studies show direct evidence of heritable disease from diagnostic radiation. ACOG and ACR jointly confirm that standard imaging doses "are at a dose much lower than the exposure associated with fetal harm."
This is the most counterintuitive finding. Lead shields placed within or near the imaging field interfere with Automatic Exposure Control (AEC) — the system that automatically adjusts radiation output based on how dense the tissue is. The AEC detects the lead as "dense tissue" and increases the radiation output to try to penetrate it. This paradoxically raises the patient's dose rather than reducing it.
Shields that migrate into the image area can obscure critical anatomy. Missed pathology or unreadable images mean a repeat exposure — which doubles the dose. Studies show this is "a more common problem than usually assumed" (AAPM PS 8-A).
| Aspect | Traditional Approach | Current Standard (2026) |
|---|---|---|
| Patient shielding | Lead apron for every X-ray | Discontinued as routine practice |
| Pregnant patients | Always shield | Case-by-case; shielding may increase dose |
| Dose reduction | Physical barrier | Built-in: AEC, digital detectors, filtration |
| Occupational shielding | Lead apron + thyroid shield | Still mandatory — no change |
| Quality assurance | Shield placement check | AEC calibration, technique optimization |
Absolutely not. ALARA is alive and well. It's not being replaced — it's being refined to reflect what we now know about radiation risk and modern technology.
The shift away from patient shielding is actually a triumph of ALARA, not an abandonment of it. Modern digital systems, AEC, copper filtration, and dose-tracking software reduce patient dose more effectively than lead aprons ever did — without compromising image quality or causing repeat exams.
In March 2026, a multisociety consensus introduced ALARA+ (As Low And as Light As Reasonably Achievable) for interventional fluoroscopy. This extends ALARA to address the dual hazard in cath labs: radiation and the orthopedic injuries caused by wearing heavy lead PPE for hours. Roughly two-thirds of interventional cardiologists report musculoskeletal pain from lead aprons. ALARA+ recommends lighter, ergonomic protection and engineered shielding.
Important: ALARA+ is for interventional/cardiology labs, not general radiography. For routine X-ray, traditional ALARA remains the standard — and it's working better than ever thanks to technology.
| Organization | Position | Year |
|---|---|---|
| AAPM (PS 8-A) | Discontinue routine patient shielding | 2019 |
| ACR | Endorsed AAPM position | 2019 |
| NCRP (Statement No. 13) | Patient shielding not recommended | 2021 |
| ASRT | Endorsed discontinuation | 2019 |
| Image Gently | Endorsed pediatric shielding changes | 2019 |
| CAR / COMP (Canada) | Endorsed AAPM position | 2020 |
| SCAI / ORSIF (ALARA+) | ALARA+ for interventional labs | 2026 |
If you're studying for the ARRT exam, know that the AAPM position statement is testable content. Questions may ask why shielding was discontinued (interferes with AEC, causes repeat exams, no proven benefit at diagnostic doses) and when an exception applies (patient anxiety).
If you're working in the field, your department likely has already implemented this change. Be prepared to explain it to patients who ask, "Aren't I supposed to get a lead apron?" A simple explanation: "Modern X-ray machines use much less radiation than before, and the shield can actually interfere with the machine's ability to take a clear image."
If you're a student, don't let outdated textbooks confuse you. Many older references still show shielding as standard practice. Follow the AAPM/ACR guidance, not the textbook from 2016.
Radiation safety hasn't gotten weaker — it's gotten smarter. The tools we use today are more precise, more effective, and backed by 70 years of evidence that didn't exist when lead aprons first became standard.